A First-in-Human Study of LY3009385 in Healthy Participants

NCT01477567 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: LY3009385
DRUG: Placebo

Sponsor

Eli Lilly and Company